Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones

Shock

Volumn 25, Issue 4, 2006, Pages 395-401

  Gonzales, Earl ^a   Chen, Huazhen ^a   Munuve, Richard ^a   Mehrani, Tina ^a   Britten Webb, Joy ^a   Nadel, Amal ^a   Alam, Hasan B ^a   Wherry, David ^a   Burris, David ^a   Koustova, Elena ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Gene expression; Hemorrhagic shock; Histone code; Histone deacetylase; Hyperacetylation; Survival; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; HEAT SHOCK PROTEIN 70; HISTONE; HISTONE DEACETYLASE INHIBITOR; HISTONE H2A; HISTONE H3; HISTONE H4; MOOD STABILIZER; SUPEROXIDE DISMUTASE; VALPROIC ACID;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CELL PROTECTION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; GENE EXPRESSION; HEMORRHAGIC SHOCK; MALE; NONHUMAN; RAT;

ACETYLATION; ANIMALS; DISEASE MODELS, ANIMAL; HEART; HEMORRHAGE; HISTONES; MALE; RATS; RATS, INBRED WKY; VALPROIC ACID;

EID: 33646821053     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000209522.28120.c8     Document Type: Article

References (39)

1. Miniño AM, Anas E, Kochanek KD, Murphy SL, Smith BL. Deaths: Final Data for 2000. National Vital Statistics Reports. Hyattsville, MD: Department of Health and Human Services (US); 50:120 pp, 2002.
2. Blaheta RA, Cinatl J Jr: Anti-tumor mechanisms of valproate: a novel role for an old drug. Med Res Rev 22:492-511, 2002.
3. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS: Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734-36741, 2001.
4. Kouzarides T: Acetylation: a regulatory modification to rival phosphorylation? EMBO J 19:1176-1179, 2000.
5. Berger SL: Gene activation by histone and factor acetyltransferases. Curr Opin Cell Biol 11:336-341, 1999.
6. Chang KT, Min KT: Regulation of lifespan by histone deacetylase. Ageing Res Rev 1:313-326, 2002.
7. Zamora R, Vodovotz Y, Aulak KS, Kim PK, Kane JM III, Alarcon L, Stuehr DJ, Billiar TR: A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: implications for hepatic heme oxygenase-1 expression in ischemia/ reperfusion. Nitric Oxide 7:165-186, 2002.
8. Alam HB, Stegalkina S, Rhee P, Koustova E: cDNA array analysis of gene expression following hemorrhagic shock and resuscitation in rats. Resuscitation 54:195-206, 2002.
9. De Sarno P, Li X, Jope RS: Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43:1158-1164, 2002.
10. Remmers DE, Wang P, Cioffi WG, Bland KI, Chaudry IH: Testosterone receptor blockade after trauma-hemorrhage improves cardiac and hepatic functions in males. Am J Physiol 273:H2919-H2925, 1997.
11. Wassarman PM, Wolffe AP, Chromatin. Methods in Enzymology, Vol. 204. San Diego, California, 1999.
12. Kline JA, Thornton LR, Lopaschuk GD, Barbee RW, Watts JA: Heart function after severe hemorrhagic shock. Shock 12:454-461, 1999.
13. Lee HB, Blaufox MD: Blood volume in the rat. J Nucl Med 26:72-76, 1985.
14. Erdemoglu AK, Ozbakir S: Valproic acid in prophylaxis of refractory migraine. Acta Neurol Scand 102:354-358, 2000.
15. Kawagoe R, Kawagoe H, Sano K: Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and independent apoptotic signaling pathways. Leuk Res 26:495-502, 2002.
16. Blaheta RA, Nau H, Michaelis M, Cinatl J Jr: Valproate and valproate-analogues: potent tools to fight against cancer. Curr Med Chem 9:1417-1433, 2002.
17. Loscher W: Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs 16:669-694, 2002.
18. Guardiola AR, Yao TP: Molecular cloning and characterization of a novel histone deacetylase HDAC10. J Biol Chem 277:3350-3356, 2002.
19. Imai S, Armstrong CM, Kaeberlein M, Guarente L: Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795-800, 2002.
20. Khochbin S, Wolffe AP: The origin and utility of histone deacetylases. FEBS Lett 419:157-160, 1997.
21. Pile LA, Wassarman DA: Chromosomal localization links the SIN3-RPD3 complex to the regulation of chromatin condensation, histone acetylation and gene expression. EMBO J 19:6131-6140, 2000.
22. Kim S, Benguria A, Lai CY, Jazwinski SM: Modulation of life-span by histone deacetylase genes in Saccharomyces cerevisiae. Mol Biol Cell 10:3125-3156, 1999.
23. Rundlett SE, Carmen AA, Kobayashi R, Bavykin S, Turner BM, Grunstein M: HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc Natl Acad Sci U S A 93: 14503-14508, 1996.
24. Bernstein BE, Tong JK, Schreiber ST: Genomewide studies of histone deacetylase function in yeast. Proc Natl Acad Sci U S A 97:13708-13713, 2000.
25. Marks PA, Richon VM, Rifkind RA: Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92: 1210-1216, 2000.
26. Roma-Giannikou E, Syriopoulou V, Kairis M, Pangali A, Sarafidou J, Constantopoulos A: In vivo effect of sodium valproate on mouse liver. Cell Mol Life Sci 56:363-369, 1999.
27. Eyal S, Yagen B, Shimshoni J, Bialer M: Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives. Biochem Pharmacol 69:1501-1508, 2005.
28. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB: Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370:737-749, 2003.
29. Kang H, Benzer S, Min KT: Life extension in Drosophila by feeding a drug. PNAS 99:838-843, 2002.
30. Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, et al: Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413:739-743, 2001.
31. Chen T, Sun H, Lu J, Zhao Y, Tao D, Li X, Huang B: Histone acetylation is involved in hsp70 gene transcription regulation in Drosophila melanogaster. Arch Biochem Biophys 408:171-176, 2002.
32. De Sarno P, Li X, Jope RS: Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43:1158-1164, 2002.
33. Bijur GN, Jope RS: Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity. J Neurochem 75:2401-2408, 2000.
34. Della Ragione F, Criniti V, Pietra Della V, Borriello A, Oliva A, Indaco S, Yamamoto T, Zappia V: Genes modulated by histone acetylation as new effectors of butyrate activity. FEBS Lett 499:199-204, 2001.
35. Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM: Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 89:1358-1367, 2004.
36. Eyal S, Yagen B, Sobol E, Altschuler Y, Shmuel M, Bialer M: The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 45: 737-744, 2004.
37. Strunnikov AV, Jessberger R: Structural maintenance of chromosomes (SMC) proteins: conserved molecular properties for multiple biologic functions. Eur J Biochem 263:6-13, 1999.
38. Tremont-Lukats IW, Megeff C, Backonja MM: Anticonvulsant for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 60:1029-1052, 2000.
39. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG, et al: Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20:6969-6978, 2001.